NeuroPace (NPCE) Change in Account Payables (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Change in Account Payables of $2.2 million in Q1 2026, up 192.03% quarter-over-quarter from -$2.4 million in Q4 2025, and up 127.23% on a YoY basis from $966000.0 in Q1 2025.
NeuroPace (NPCE) Change in Account Payables (2020 - 2026) Analysis & Trends
NeuroPace's Change in Account Payables history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 127.23% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $499000.0 (down 27.37% YoY), while the FY2025 annual figure was -$730000.0, down 208.79% from the prior year.
- Change in Account Payables was $2.2 million for Q1 2026 at NeuroPace, up from -$2.4 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q1 2026 to a low of -$2.4 million in Q4 2025.
- Historically, Change in Account Payables has averaged $177823.5 across 5 years, with a median of -$22000.0 in 2023.
- Biggest YoY gain for Change in Account Payables was 592.23% in 2024; the steepest drop was 4090.91% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $855000.0 in 2022, then climbed by 23.39% to $1.1 million in 2023, then retreated by 26.73% to $773000.0 in 2024, then sank by 408.54% to -$2.4 million in 2025, then surged by 192.03% to $2.2 million in 2026.
- The last three Change in Account Payables figures came in at $2.2 million (Q1 2026), -$2.4 million (Q4 2025), and -$48000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Sep 30, 2025 | -48,000.00 |
| Sep 30, 2025 | -48,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |